世界中医药2012，Vol.7Issue(2)：164-165,2.
"生血二号"治疗特发性血小板减少性紫癜对巨核细胞影响的实验研究
Impact of ShengxueⅡ on Megalocaryocyte in Mice with Idiopathic Thrombocytopenic Purpura
宋明福 1王安桥 2朱国龙 1刘敏2
作者信息
- 1. 宜昌市中医院,湖北省宜昌市胜利三路2号,443003
- 2. 三峡大学中医临床医学院
- 折叠
摘要
Abstract
Objective: To observe the impact of Shengxue II on megalocaryocyte in bone marrow in mice with idiopathic thrombocytope-nic purpura ( FTP ). Methods:Thirty male and female mice with thrombocytopenia were treated by Chinese medicine, or by hormone respectively for 15 days, and megalocaryocyte in bone marrow were counted. Results:Either the medicine group or hormone group had significant differences when comparing with the model group ( P <0.01 ); but without significant differences when comparing with the normal group ( P >0. 05 ); There was no significant different between the medicine group and hormone group ( P >0. 05 ). Conclusion: Shengxue II can promote megalocaryocyte differentiation and produce blood platelet, indicating it is a safer and more effective treatment than hormone for the treatment of idiopathic thrombocytopenic purpura.关键词
血小板减少性紫癜/中医药疗法/巨核细胞/生血二号Key words
Idiopathic thrombocytopenic purpura/ Chinese medical therapy/ Megalocaryocyte @ Shengxue II引用本文复制引用
宋明福,王安桥,朱国龙,刘敏.."生血二号"治疗特发性血小板减少性紫癜对巨核细胞影响的实验研究[J].世界中医药,2012,7(2):164-165,2.
